The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Reading miRNAs for Clinical Meaning
Single miRNAs Don’t Say Much, but They May Become Eloquent Biomarkers if We Take Their Testimony in Context
Sorting Out the CRISPR Patent Case
Sounds of Science Podcast
For full access to this article login to GEN Select now.
Strategies for Removing Viruses from Cell Lines
Firms Pursue New and More Effective Methods in Their Efforts to Reduce Risk
- Cell culture productivity has improved 50-fold during the past 20 years, leading to bottlenecks in downstream processing. Increasingly high titers have further slowed processes. During the same period, new agents and contamination risks have emerged that have required companies to discover new and more effective methods to remove viruses ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.